BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $125 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $54.80 -0.16%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Baird analyst Michael Ulz raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $125.00 (from $120.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BioMarin presents Voxzogo skeletal dysplasia data at ASBMR meeting
- Owens Corning (OC) PT Lowered to $143 at DA Davidson
- RPM International (RPM) PT Lowered to $117 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
